BPG is committed to discovery and dissemination of knowledge
Observational Study
Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Nov 15, 2026; 18(11): 123962
Published online Nov 15, 2026. doi: 10.4251/wjgo.123962
Figure 1
Figure 1 Design and patients enrolled in this study. Reasons for exclusion during the 5-year follow-up included: Loss to follow-up (n = 42), self-discontinuation of treatment (n = 18), and development of decompensated cirrhosis (n = 9). HCC: Hepatocellular carcinoma; HBV: Hepatitis B virus; HCV: Hepatitis C virus; NAs: Nucleos(t)ide analogs; IFN: Interferon.


Write to the Help Desk